These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27112707)

  • 21. Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines.
    Thomas CW; Myhre GM; Tschumper R; Sreekumar R; Jelinek D; McKean DJ; Lipsky JJ; Sandborn WJ; Egan LJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):537-45. PubMed ID: 15388785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
    Jharap B; de Boer NK; Stokkers P; Hommes DW; Oldenburg B; Dijkstra G; van der Woude CJ; de Jong DJ; Mulder CJ; van Elburg RM; van Bodegraven AA;
    Gut; 2014 Mar; 63(3):451-7. PubMed ID: 23424097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism.
    Shih DQ; Nguyen M; Zheng L; Ibanez P; Mei L; Kwan LY; Bradford K; Ting C; Targan SR; Vasiliauskas EA
    Aliment Pharmacol Ther; 2012 Sep; 36(5):449-58. PubMed ID: 22784257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study.
    Seinen ML; van Asseldonk DP; de Boer NK; Losekoot N; Smid K; Mulder CJ; Bouma G; Peters GJ; van Bodegraven AA
    J Crohns Colitis; 2013 Nov; 7(10):812-9. PubMed ID: 23317929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease.
    Jergens A; Young J; Moore D; Wang C; Hostetter J; Augustine L; Allenspach K; Schmitz S; Mosher C
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):167-74. PubMed ID: 24495616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD.
    de Boer NK; van Bodegraven AA; Jharap B; de Graaf P; Mulder CJ
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):686-94. PubMed ID: 18043678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A histopathologic pattern of centrilobular hepatocyte injury suggests 6-mercaptopurine-induced hepatotoxicity in patients with inflammatory bowel disease.
    Masia R; Pratt DS; Misdraji J
    Arch Pathol Lab Med; 2012 Jun; 136(6):618-22. PubMed ID: 22646267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-Mercaptopurine reduces macrophage activation and gut epithelium proliferation through inhibition of GTPase Rac1.
    Marinković G; Hamers AA; de Vries CJ; de Waard V
    Inflamm Bowel Dis; 2014 Sep; 20(9):1487-95. PubMed ID: 25029617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are thiopurines always contraindicated after thiopurine-induced pancreatitis in inflammatory bowel disease?
    Ledder OD; Lemberg DA; Ooi CY; Day AS
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):583-6. PubMed ID: 23783022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.
    Seidman EG
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S30-8. PubMed ID: 12684587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ
    Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
    [No Abstract]   [Full Text] [Related]  

  • 32. Getting the best out of thiopurine therapy: thiopurine S-methyltransferase and beyond.
    Fong SC; Blaker PA; Arenas-Hernandez M; Marinaki AM; Sanderson JD
    Biomark Med; 2015; 9(1):51-65. PubMed ID: 25605455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease.
    Hindorf U; Johansson M; Eriksson A; Kvifors E; Almer SH
    Aliment Pharmacol Ther; 2009 Mar; 29(6):654-61. PubMed ID: 19183142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
    Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
    Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
    Su C; Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.
    Ooi CY; Bohane TD; Lee D; Naidoo D; Day AS
    Aliment Pharmacol Ther; 2007 Apr; 25(8):941-7. PubMed ID: 17402998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of azathioprine and its metabolites on repair mechanisms of the intestinal epithelium in vitro.
    Schroll S; Sarlette A; Ahrens K; Manns MP; Göke M
    Regul Pept; 2005 Nov; 131(1-3):1-11. PubMed ID: 16122821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
    Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
    Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD147 inhibits the nuclear factor of activated T-cells by impairing Vav1 and Rac1 downstream signaling.
    Ruiz S; Castro-Castro A; Bustelo XR
    J Biol Chem; 2008 Feb; 283(9):5554-66. PubMed ID: 18160397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
    Sparrow MP; Hande SA; Friedman S; Lim WC; Reddy SI; Cao D; Hanauer SB
    Aliment Pharmacol Ther; 2005 Sep; 22(5):441-6. PubMed ID: 16128682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.